Change in Orion Group Executive Team as of 8 April 2026 – Berkeley Vincent appointed Executive Vice President, Innovative Medicines4/1/2026 Stock exchange release
ORION CORPORATION STOCK EXCHANGE RELEASE – CHANGES BOARD/MANAGEMENT/AUDITORS 1 APRIL 2026 at 16.00 E...
Publisher
Finland
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalIn-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Summary excerpt
ORION CORPORATION STOCK EXCHANGE RELEASE – CHANGES BOARD/MANAGEMENT/AUDITORS 1 APRIL 2026 at 16.00 E...
Source route
Continue on orionpharma.com
Leave the platform to read the original full article on the publisher site.
Source: Orion Corporation
Scope: Industry
Related coverage
More related coverage
Bristol Myers Squibb to Report Results for First Quarter 2026 on April 30, 2026
Shionogi Completes Acquisition of All Rights to RADICAVA (edaravone)
Apr 2, 2026How Us2.ai and Merge Are Bringing AI Echo Directly Into Clinical WorkflowsRepresentatives from Us2.ai and Merge sat down with the Cardiac Wire Show to discuss their new integration and what it means for the echo techs and cardiologists who use it everyday. Together, the two...
Lilly’s Announcement Regarding Oral GLP-1 Foundayo™ (Orforglipron)
TOKYO, April 2, 2026 -- Chugai Pharmaceutical Co., Ltd. (hereafter “Chugai”, TOKYO: 4519) announced...